Atea Pharmaceuticals Says Hepatitis C Drug Matches Gilead's in Pivotal Trial - Atea Pharmaceuticals (NASD

Atea Pharmaceuticals announced positive Phase 3 C-BEYOND trial results for its oral hepatitis C combination therapy vs. Gilead's therapy.

Raccontata dabenzinga.com